Study of a Phakic Implantable Collamer Lens (ICL)

N/ANot Yet RecruitingNCT07790965

Staar Surgical Company10 enrolled

Overview

A prospective, open-labeled, single-site study of a phakic implantable collamer lens (ICL) for the correction/reduction of myopia with or without astigmatism.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Myopia Astigmatism

Interventions

Phakic Implantable Collamer Lens (ICL)DEVICE

Diffractive Trifocal Phakic ICL

Eligibility

Sex: ALLMin age: 21 YearsMax age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Must be between the age of 21 - 60 years * Must be suitable for ICL surgery, * Must meet all unique study eligibility criteria Exclusion Criteria: * Outside the age of 21 - 60 years, * Not a suitable candidate for ICL surgery, * Does not meet all unique study eligibility criteria

Outcomes

Primary Outcomes

Cumulative and Persistent Adverse Events

Safety Population

Time frame: 3 Months

Central Contacts

Laura Director, Clinical Affairs

CONTACT

336-306-0587 lschall@staar.com

Jennifer Lynch

CONTACT

jlynch@staar.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.